“People are not getting the same care”: health disparities and Parkinson’s
Author: Sophie BatesPublished: 20 August 2020
Prep: Cook: Serves:
Five experts discuss the health disparities faced by people with Parkinson’s, why healthcare inequalities have been neglected for so long – and what needs to change
A recent webinar hosted by US Parkinson’s charity Davis Phinney Foundation, in partnership with Dance for PD, invited a panel of experts to talk about the inequities in healthcare experienced by black, brown, indigenous, LGBTQ+, immigrant and refugee communities in the US. We share three key takeaways from their discussion.
David Leventhal, programme director of Dance for PD, kicked off the talk by recognising that the lack of diversity at events, classes and support groups for Parkinson’s is not “an accident” but “the result of deeply rooted systemic health and cultural inequalities, inequities and disparities”.
“As somebody who leads dance classes for people with Parkinson’s around the US, I witness inspiring participation from thousands of people, but a notable lack of racial and cultural diversity in those programmes,” says Leventhal. “For an art form like dance, that lives among and celebrates all cultures, all people and all bodies – it is particularly disheartening to know that there are so many people that are not yet in the room with us.”
“Our current system is not set up in a way to help them get an early diagnosis or the best possible care,” says Dr Mejia. “The Parkinson’s community really needs to think about and change the diversity in our healthcare teams. Across the continuum, we need greater diversity – racial, ethnic, linguistic and gender – so that patients have a different experience.”
For example, says Dr Mejia, when it comes to clinical research it has been found that lead researchers who speak languages other than English “tend to be more mindful about translating all their clinical research forms into other languages and recruiting people who speak other languages.”
“People are not getting the same care,” says Dr Nabila Dahodwala. In her research into health disparities, Dr Dahodwala found that people who do not speak English in the US and who start to experience symptoms of Parkinson’s are often unsure of where to go or who to tell.
2. Building trust through cultural understanding
When it comes to earning patient trust, Dr Jonathan Jackson, executive director of the Community Access, Recruitment and Engagement (CARE) Research Center at Massachusetts General Hospital, says: “Trust is not where you begin, you begin with empowerment and partnership.
“The best physician is one who can understand you, can understand what’s important to you and can connect you to services, medications, treatment – and can build a plan with you that takes into consideration all of the contextual needs and desires that you have.”
Dr Claudia Martinez, Hispanic outreach coordinator, Muhammad Ali Parkinson Center, says she builds trust with people in the Parkinson’s community by “understanding their cultures, the environment that they live in and where they come from.
“You need to build what I call ‘cultural empathy’, when you’re willing to put yourself in the shoes of that community.”
Dr Mejia shares that in her practice, she starts her appointments by asking patients to talk her through their life as a way of avoiding assumptions.
Dr Altaf Saadi, a neurologist at Massachusetts General Hospital who works with individuals that have fled persecution in their home countries from across the world, says there is a need for a wider community involvement in healthcare to improve trust: “We need to be thinking about doing research that is partnered with community-based organisations. We can’t start with the assumption that people are going to trust us because we’re doctors.”
3. Starting conversations
To improve the inequities in healthcare, we need to have difficult conversations, says Dr Jackson. He emphasises that professionals should not hold back on starting conversations: “Don’t wait until you have perfect representation on your team, all the resources in place and a very detailed plan that is well-funded and sustainable before you reach out to the community.”
Instead, Dr Jackson says, professionals should “be vulnerable” and recognise areas where they may lack understanding. “Do not make assumptions about how the conversation is supposed to go or that somebody should be grateful that you’re there,” he advises.
Four Parkinson’s experts share their hopes for the future of DBS
6 days ago
Antioxidants could reduce risk of Parkinson’s disease by 32%, study finds
Antioxidant vitamins, found in foods like almonds, avocados and broccoli, could reduce the risk of Parkinson’s disease, researchers in Sweden have reported. The scientists analysed data from a study of 43,865 men and women, aged between 18 and 94. Participants were asked to share information about their diets when the study began and were then monitored through health records over an average of almost 18 years. The researchers found that those who had reported high levels of vitamins C and E – which help prevent cell damage and inflammation – had a 32% lower risk of developing Parkinson’s disease. “Our findings suggest that dietary vitamin E and C intake might be inversely associated with the risk of Parkinson disease,” the scientists concluded.
Weight, sleep and depression linked to risk of cognitive problems in Parkinson’s
Researchers at the University of Pennsylvania, US, have found that people with early Parkinson’s disease are at higher risk of developing cognitive impairments if they are overweight, have disruptive sleep behaviours or experience symptoms of depression. Evaluating data from 405 people, the researchers used statistical analysis to identify relationships between certain characteristics and changes in patient cognition over time. Their findings suggest that factors such as high body mass index (BMI) or excessive sleepiness are associated with a faster rate of cognitive decline in Parkinson’s disease. The researchers wrote: “Despite its common and devastating occurrence, treatment of [cognitive impairments] in [Parkinson’s disease] is limited and no medications slow its onset or progression. However, identification of treatable or modifiable comorbidities that affect the rate of progression of [cognitive impairments] in [Parkinson’s disease] could provide opportunities for early intervention and improved prognosis.”
Gene screening technique could offer insights on Parkinson’s disease
Researchers from the Massachusetts Institute of Technology (MIT), US, will investigate genes that could protect cells in the brain against Parkinson’s disease. An award from US non-profit G Harold and Leila Y Mathers Foundation will allow scientists to use a mouse model screening technique to find out more about the condition. Individually deleting each of the 22,000 genes present in mice neurons will help identify which genes are linked to neuron survival – and offer insights that could lead to new treatments for the condition. Dr Myriam Heiman, an Associate Professor at MIT, said: “There is currently no molecular explanation for the brain cell loss seen in Parkinson’s disease or a cure for this devastating disease. I’m extremely grateful for this generous support and recognition of our work from the Mathers Foundation, and hope that our study will elucidate new therapeutic targets for the treatment and even prevention of Parkinson’s…